An intra-cardiac mass in a patient with Behçet's disease: Cardiac hydatid cyst

Mehmet Rasih Sonsoz1, Sevki Can Gunes2

  • 1Department of Cardiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Insights

Cardiac hydatid cysts are rare, mimicking cardiac thrombi in Behçet's disease patients. This case highlights the importance of considering parasitic infections in intra-cardiac masses, even with a history of thrombosis.

Area of Science:

  • Cardiology
  • Parasitology
  • Rheumatology

Background:

  • Cardiac hydatid cysts are uncommon, affecting 0.5%-2% of human hydatidosis cases.
  • Behçet's disease is a systemic vasculitis frequently linked to venous thrombosis.
  • Intra-cardiac masses in Behçet's disease patients often raise suspicion for thrombosis.

Observation:

  • A 32-year-old male with Behçet's disease and a history of venous thrombosis presented with an intra-cardiac mass.
  • Initial echocardiogram suggested an intra-cardiac thrombus.
  • Subsequent echocardiography and cardiac magnetic resonance confirmed a hydatid cyst in the right ventricular apex.

Findings:

  • A hydatid cyst was diagnosed in the right ventricular apex.
  • The cyst was initially misdiagnosed as an intra-cardiac thrombus due to the patient's history of Behçet's disease and venous thrombosis.
  • Diagnostic imaging modalities including echocardiogram and cardiac MRI were crucial for accurate diagnosis.

Implications:

  • This case underscores the need to consider parasitic etiologies, such as hydatid cysts, in the differential diagnosis of intra-cardiac masses.
  • It highlights potential diagnostic challenges in patients with co-existing conditions like Behçet's disease.
  • Accurate and timely diagnosis of cardiac hydatid cysts is essential for appropriate management and to prevent complications.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
297
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
246
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
361
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
157
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
418
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
225